Influence of dose adjustment on afatinib safety and efficacy in patients (pts) with advanced EGFR mutation-positive (EGFRm plus ) non-small cell lung cancer (NSCLC)
Resource
Ann. Oncol., 26, 77-77
Journal
Ann. Oncol.
Journal Issue
26
Pages
77-77
Date Issued
2015
Date
2015
Author(s)
Passaro, A.
Yang, J. C.
Ahn, M.
Dickgreber, N. J.
Halmos, B.
Hirsh, V.
Hochmair, M. J.
Levy, B. P.
de Marinis, F.
Mok, T.
O'Byrne, K.
Okamoto, I.
Schuler, M.
Sebastian, M.
Shah, R.
Tan, E.
Yamamoto, N.
Maerten, A.
Wind, S.
Carbone, D. P.
SDGs